Welcome to the world of Influenza
>
News & Publications
>
Solvay’s cell-based production facility for Influenza vaccines validated and operational
Other Solvay Sites
------------------------------------------------
Solvay.com
---------- Business Portals ----------
PHARMACEUTICALS PORTAL
Aceon
Androgel
Depression Center
Duodopa
Duphalac
Duphalac Italy
Influenza Center
Irritable Bowel Syndrome
Lactulose
Marinol
Menopause Center
Moses Study
Solvay Arzneimmittel
Solvay Healthcare
Solvay Injectables
Solvay Omacor
Solvay Pharma Belgium
Solvay Pharma Canada
Solvay Pharma Espana
Solvay Pharma Schweiz
Solvay Pharmaceuticals - AMAC
Solvay Pharmaceuticals NL
Solvay Pharmaceuticals US
Teveten
CHEMICALS PORTAL
PLASTICS PORTAL
> Other sites by Businesses
----------- Country Portals -----------
Solvay Austria
Solvay China
Solvay Seiyaku
Solvay Deutschland
Solvay France
Solvay Iberica
Solvay Italia
Solvay Nordic
Solvay North America
Solvay Portugal
Solvay Schweiz
> Other sites by Regions
Deze site
Alle sites
SOLVAY.COM
SOLVAY INFLUENZA
version:
[EN]
-
[FR]
-
> 09 september, 2009<
Solvays celcultuurfabriek voor griepvaccins is gevalideerd en operationeel
|
Gelieve dit per E-mail toe te sturen
|
© Solvay S.A • Belangrijke informatie :
Privacy Policy
-
Disclaimer
• Voor commentaar en opmerkingen kunt u contact opnemen met de
webmaster
Datum laatste wijziging: 6/7/2010
